Patents by Inventor José-Manuel CANCELA

José-Manuel CANCELA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11253535
    Abstract: A method of treating Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), a cardiomyopathy or a muscular traumatism in a subject includes administering to the subject certain ADP ribosylcyclase antagonist compounds, certain cyclic ADP ribose (cADPR) antagonist compounds, certain nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist compounds or a mixture of these compounds.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: February 22, 2022
    Assignee: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: José-Manuel Cancela, Sabine De La Porte, Antoine De Zelicourt
  • Publication number: 20190022122
    Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds for preventing and/or treating, in a subject, myopathy, typically muscular dystrophy or cardiomyopathy, or muscular trauma. The invention also relates to the compositions, in particular pharmaceutical compositions comprising such compounds, as well as their uses for preventing and/or treating muscular myopathy or trauma. The compounds and compositions according to the invention may typically be advantageously used to prevent and/or treat muscular dystrophy, cardiomyopathy or muscular trauma, preferably Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD) and/or a characteristic symptom or anomaly of DMD or BMD.
    Type: Application
    Filed: December 9, 2016
    Publication date: January 24, 2019
    Inventors: José-Manuel CANCELA, Sabine DE LA PORTE, Antoine DE ZELICOURT